MHC Class II-Restricted Antigen Presentation by Plasmacytoid Dendritic Cells Drives Pro-Atherogenic T Cell Immunity Running title: Sage et al.; MHC II expression by pDC promotes atherosclerosis

Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom; Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; Institut National de la Santé et de la Recherche Médicale, Unit 970, Paris Cardiovascular Research Center, Paris, France; Dept of Pharmacy, University of Naples Federico II, Naples, Italy; Institute of Immunobiology, Kantonal Hospital St. Gallen, St. Gallen, Switzerland; Dept of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Molecular Medicine, Dept of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden; Dept of Microbiology and Immunology, Columbia University Medical Center, New York; Dept of Pathology, University of Geneva Medical School, Geneva, Switzerland